chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: DTAPIPVHIB, FLU4, HIBV, IPV
Symptoms: No adverse event, Product storage error
Clinical narrative: Low temperature reached: 26.9F out of range intermittently for 12 days , with no reported adverse event; Excursion product administered to patient; Initial information received on 12-Apr-2022 regarding an unsolicited valid non-serious case received from a healthcare professional.  This case involves an unknown age female patient who reported that low temperature reached: 26.9 F out of range intermittently for 12 days, with no reported adverse event and excursion product administered to patient while receiving vaccines Poliomyelitis Vaccine (Inactivated) (IPOL), Diphtheria, Tetanus, Ac Pertussis, IPV and HIB Vaccine (Pentacel), HIB Vaccine CONJ (Tet Tox) (ACTHIB) And Quadrivalent Influenza Vaccine (Fluzone Quadrivalent).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect IPV (Vero) (Poliomyelitis Vaccine (Inactivated) )(lot TIE871M and expiry 10-Oct-2022), Diphtheria, Tetanus, Ac Pertussis, IPV(Pentacel), ActHIB (not produced by Sanofi Pasteur) and Influenza Quadrival A-B Vaccine (Fluzone Quadrivalent) (strength, dosage, route, administration site, expiry date: unknown). Information on Lot number is not reported.  On an unknown date the patient reported low temperature reached: 26.9f out of range intermittently for 12 days, with no reported adverse event" (product temperature excursion issue) excursion product administered to patient (Product use issue) (unknown latency) following the administration of IPV (Vero) (Poliomyelitis Vaccine (Inactivated) )(lot TIE871M and expiry 10-Oct-2022), Diphtheria, Tetanus, Ac Pertussis, IPV (Pentacel), ActHIB (not produced by Sanofi Pasteur) and Influenza Quadrival A-B Vaccine (Fluzone Quadrivalent).  It was reported that Caller reporting she was sure products have been administered but have to look through data to determine affected patients.  Action taken: not applicable.  It was not reported if the patient received a corrective measurement for the event (Low temperature reached: 26.9F out of range intermittently for 12 days, with no reported adverse event).  At time of reporting, the outcome was Unknown for the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 53.0
Sex: M
Vaccine: TDAP
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received an expired dose of ADACEL with no reported adverse event; Initial information received on 12-Apr-2022 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 53 years old male patient who experienced patient received an expired dose of adacel with no reported adverse event while receiving vaccine Diphtheria-2/Tetanus/5 AC Pertussis Vaccine [Adacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 09-Apr-2022, the patient received first dose 0.5 mL of suspect diphtheria-2/tetanus/5 ac pertussis vaccine expiry date: Nov-2021 (form, strength, lot number, route and administration site: unknown) for Immunization.  On an unknown date the patient developed a non-serious patient received an expired dose of adacel with no reported adverse event (expired product administered) (unknown latency) following the administration of diphtheria-2/tetanus/5 ac pertussis vaccine.  It was reported that the "Patient received an expired dose of ADACEL in the facility on 09APR2022. Pharmacist states that the adacel expired in November of 2021 but lot number and expiration date are not available because the adacel has been discarded. This situation is reported as a medication error due to the adacel being expired when administered. Event Information o Treatment o Dose # if series-This was the patient's second dose. The first dose was given on 23MAY2011".   Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: TDAP
Symptoms: Medication error, No adverse event, Product storage error
Clinical narrative: one dose of ADACEL was given post excursion with no reported adverse event; excursion lasted for 15 minutes and the maximum temperature of the refrigerator reached 8.8 degrees Celsius; Initial information received on 12-Apr-2022 regarding an unsolicited valid non-serious case received from healthcare professional.  This case involves an unknown demographic patient to whom one dose of adacel was given post excursion with no reported adverse event and excursion lasted for 15 minutes and the maximum temperature of the refrigerator reached 8.8 degrees celsius while receiving vaccine Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine (lot U6807BA and expiry 21-Sep-2022) (strength, dosage, formulation, route, administration site: unknown) for immunization.  On an unknown date the patient reported with one dose of adacel was given post excursion with no reported adverse event (product use issue) and excursion lasted for 15 minutes and the maximum temperature of the refrigerator reached 8.8 degrees celsius (product temperature excursion issue) (unknown latency) following the administration of Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine.  It was reported that caller does not have any patient information available at this time.  Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine was discontinued on an unknown date.  It was not reported if the patient received a corrective measurement for both the events.  At time of reporting, the outcome was Unknown for both the events.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 3.0
Sex: F
Vaccine: IPV
Symptoms: No adverse event, Product storage error
Clinical narrative: patient that received an ipol vaccination after the temperature excursion occurred with no adverse event; excursed vaccine administered to the patient; Initial information received on 12-Apr-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 3 years old female patient that received an ipol vaccination after the temperature excursion occurred with no adverse event with excursed vaccine administered to the patient while receiving vaccine IPV (Vero) [IPOL] poliomyelitis vaccine (inactivated)  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) for Prophylactic vaccination.  On 10-Mar-2022, the patient received a dose 0.5 mL (millilitre) of suspect IPV (VERO) (lot T1E871M, expiry date: 10-Oct-2022) via intramuscular route (strength, form not reported) on an unknown administration site for Immunization    On 10-MAR-2022, it was reported as patient that received an ipol vaccination after the temperature excursion occurred with no adverse event (product administration error) and excursed vaccine administered to the patient (Product use issue) (Latency: same day)  Action taken: not applicable for both the events.  Outcome: Unknown for both the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  01059755:
Age: 1.0
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: No adverse event, Product preparation issue
Clinical narrative: patient was given the Hib powder portion of Pentacel that had been reconstituted with sterile water rather than the DTap-IPV liquid diluent with no adverse event; Initial information received on 12-Apr-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 1-year-old female patient who was given the hib powder portion of pentacel that had been reconstituted with sterile water rather than the dtap-ipv liquid diluent with no adverse event while receiving vaccine diphtheria/tetanus/5 hybrid ac pertussis/ipv(mrc5)/hib(prp/t) vaccine [pentacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included pneumococcal vaccine conj 13v (crm197) (prevnar 13) for Immunisation.  On 08-Apr-2022, the patient received a dose of suspect diphtheria/tetanus/5 hybrid ac pertussis/ipv(mrc5)/hib(prp/t) vaccine with unknown dosage form and strength with lot number UJ591AA and expiration date 18-Dec-2022 via intramuscular route in the left thigh for immunization.  On 08-APR-2022 the patient was given the hib powder portion of pentacel that had been reconstituted with sterile water rather than the dtap-ipv liquid diluent with no adverse event (product preparation error) during the administration of diphtheria/tetanus/5 hybrid ac pertussis/ipv(mrc5)/hib(prp/t) vaccine.  It was reported "office supervisor states that a medical assistant recently noticed that there was still one liquid DTap-IPV vial of PENTACEL remaining in the box and discovered that a patient was given the Hib powder portion of PENTACEL on 08APR2022 that had been reconstituted with sterile water provided by Varivax rather than the DTap-IPV liquid diluent from the PENTACEL box. Caller wanted to know whether the Hib portion would count as valid or if the patient needed to be revaccinated with PENTACEL".   Action taken with diphtheria, tetanus, ac pertussis, ipv and hib vaccine (pentacel) was not applicable.  It was not reported if the patient received a corrective treatment for the event (patient was given the Hib powder portion of Pentacel that had been reconstituted with sterile water rather than the DTap-IPV liquid diluent with no adverse event).  At time of reporting, the outcome was Unknown for the event patient was given the hib powder portion of pentacel that had been reconstituted with sterile water rather than the dtap-ipv liquid diluent with no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 14.0
Sex: F
Vaccine: MNQ
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 14-year-old patient was given the menactra injection today with no reported adverse event; Initial information received on 13-Apr-2022 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 14-year-old female patient (last menstrual period: 12-Apr-2022) who was given the meningococcal A-C-Y-W135 (D CONJ) vaccine [Menactra] today with no reported adverse event.      The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Hpv Vaccine VLP RL1 4V (Yeast) (Gardasil) for Prophylactic vaccination.   On 25-Apr-2019, the patient received Dose-1 for meningococcal a-c-y-w135 (d conj) vaccine via intramuscular route in the left deltoid once (Strength: standard, frequency: once) (dose, lot/batch number and expiry date: unknown) and on 13-Apr-2022 received Dose:2 at a dose of 0.5 mL total via intramuscular route in the left deltoid total  (Strength: standard, frequency: once) (lot: U7211AB, expiry date: 14-Mar-2023) for immunization.  On 13-Apr-2022 the patient received menactra injection with no reported adverse event (Product administered to patient of inappropriate age) (Latency was 2 years 11 months 19 days from Dose:1 and same day from Dose:2) following the administration of meningococcal a-c-y-w135 (d conj) vaccine.   It was reported that "Educator from a MD office called to advise that a 14-year-old patient was given the menactra injection today. The patient was given the first injection of menactra three years ago on 25-Apr-2019. Caller asked if the dose needs to be repeated at age 16. This was reported as a potential adverse event because of use against local labelling (underage for booster)."    Action taken was not applicable.  Corrective treatment was not reported  At time of reporting, the outcome was Unknown.     This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: F
Vaccine: TD
Symptoms: Expired product administered
Clinical narrative: tenivac that expired on march 2022, exact date unsure, was administered to patient with no adverse event; Initial information received on 14-Apr-2022 regarding an unsolicited valid non-serious case received via other health professional.  This case involves an unknown age female patient who experienced tenivac that expired on march 2022, exact date unsure, was administered to patient with no adverse event while receiving vaccine DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT (Tenivac).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 11-Apr-2022, the patient received a dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT (dose, route, lot number and administration site: unknown) expiry date: Mar-2022 for Immunization (expired product administered) (latency: same day).  Reportedly asking if the patient needs another dose or if there are any advice for reactions.   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (tenivac that expired on march 2022, exact date unsure, was administered to patient with no adverse event).  At time of reporting, the outcome was Unknown for the event tenivac that expired on march 2022, exact date unsure, was administered to patient with no adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: F
Vaccine: FLUX
Symptoms: Rash
Clinical narrative: rash all over body and rash keeps growing; Initial information received on 15-Apr-2022 regarding an unsolicited valid non-serious case received from a patient via phone.  This case involves a female patient who experienced, "rash all over body and rash keeps growing" while receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.    On an unknown date, the patient received a dose of suspect Influenza Vaccine at (unknown formulation, strength, dose, route, frequency, batch number and expiry date) produced by unknown manufacturer in unknown administration site for prophylactic vaccination [immunization].  On an unknown date, the patient reported a non-serious event, "rash all over body and rash keeps growing" (rash) (unknown latency) following the administration of Influenza Vaccine.  It was reported by the patient that, "she is calling to report an adverse event with the flu product. Caller states the clinic convinced her to get the flu vaccine. She has a rash all over her body and she got the flu vaccine in December and the rash keeps growing. Caller did not know which flu vaccine she received an will call back with the flu product and lot and expiration information. Reporter relationship : Self".  Action taken with Influenza Vaccine was not applicable.   At time of reporting, the outcome was Unknown for the event, "rash all over body and rash keeps growing".
Sex: F
Vaccine: YF
Symptoms: Incorrect route of product administration
Clinical narrative: She administered one intramuscularly instead of subcutaneous with no reported adverse event; Initial information received on 15-Apr-2022 regarding an unsolicited valid non-serious case received from other health professional via call center.  This case involves an unknown age female patient who was administered one intramuscularly instead of subcutaneous with no reported adverse event while receiving vaccine yellow fever vaccine -  [YF-VAX].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included typhoid vaccine (Typhim) for Prophylactic vaccination.  On 15-Apr-2022, the patient received suspect yellow fever vaccine - at a dose of 0.5 ml once (lot number, form, strength: not reported) via intramuscular route in unknown administration site on left side for immunization.  On 15-Apr-2022 the patient was administered one intramuscularly instead of subcutaneous with no reported adverse event (incorrect route of product administration) (same day latency) following the administration of yellow fever vaccine - .  Action taken: not applicable.  Outcome: Unknown.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 54.0
Sex: F
Vaccine: COVID19, VARZOS
Symptoms: Eye contusion, Eye oedema, Ocular hyperaemia
Clinical narrative: Woke up 4/19 with edema under both eyes.  No swelling anywhere else (rings on fingers were easily removed, no gain in weight, eyelids and eyes were unchanged).  Under eye edema felt "bruised" and appeared reddish/purple in color.  Today, 4/20, woke up with slightly less edema, slightly less pain, still purple
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Client received her COVID Pfizer Pediatric dose lot # FK5618 exp. 01.28.22 on her left arm on 12.11.21. At 1438, client reported to RN that she was feeling ?lightheadedness,? wanted to lay down and closed her eyes, and nurse transported client to the anti-gravity chair in a semi-fowler position. Client denied shortness of breath (SOB) or any chest pain. At 1454, RN took client?s vitals: BP 76/45, HR 55, O2 Sat. 100%, and client is alert and oriented x 4. At 1501, RN took client?s vitals: BP 89/71, HR 98, O2 Sat. 100%. Client denied SOB or any other anaphylactic signs and symptoms. She denied any history of allergy or taking any medications. Client?s mother reported that her daughter ?feel the same? when she took her to the dentist last time. At 1506, RN took client?s vitals: BP 82/69, HR 82, O2 Sat. 100%, and client denied ?lightheadedness? or any other symptoms. Client told she ?feels good.? At 1509, client reported she was ?feeling better? and denied any ?lightheadedness? or any other symptoms. At 1509, client walked with a steady gait to sit on a chair next to her mother after her mother received her vaccination at the EMT station. At 1524, nurse took client?s vitals: BP 98/72, HR 83, O2 Sat. 100% at the EMT station. At 1524, nurse educated client?s mother on adverse reactions and when to seek EMS. Nurse referred client?s mother to take client to follow-up in a week with client?s pediatrician before her second COVID dose. At 1528, client left the vaccination site with a steady gait with her mother.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Starting the day after vaccine shot, stool turned from normally solid to liquid and has remained mostly liquid, and frequent, to the current day.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Chills, Headache, Myalgia, Oedema peripheral
Clinical narrative: Headache, Myalgia,  chills, arm soreness, right axilla had a lump Narrative: States her headache has been the most intense, has been afebrile. Right axilla became swollen with a lump. Taking Tylenol and Benadryl OTC.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Headache, Myalgia,  chills, arm soreness, right axilla had a lump Narrative: States her headache has been the most intense, has been afebrile. Right axilla became swollen with a lump. Taking Tylenol and Benadryl OTC.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, COVID-19, Diarrhoea, Hypophagia, Myalgia
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 08/23/2021.  34 y/o male with PMHx of Type 2 Diabetes presents to ED with c/o intractable Nausea, Vomiting and Diarrhea.  Pt also endorses fevers, diffuse abdominal pain, generalized muscle aches and poor po intake.  Temp max in ED 101.2, room air sat 99%.  Pt treated with steroids.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pyrexia, SARS-CoV-2 test positive, Vaccine breakthrough infection, Vomiting
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 08/23/2021.  34 y/o male with PMHx of Type 2 Diabetes presents to ED with c/o intractable Nausea, Vomiting and Diarrhea.  Pt also endorses fevers, diffuse abdominal pain, generalized muscle aches and poor po intake.  Temp max in ED 101.2, room air sat 99%.  Pt treated with steroids.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Limb injury
Clinical narrative: Site: Pain at Injection Site-Medium, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Age: 99.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Fatigue, SARS-CoV-2 test positive
Clinical narrative: 7/4/21 hx of PE in past, hx of gastric ulcer not on AC, hx of CHF presented with chief c.o cough, SOB and fatigue
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dysuria, Oedema peripheral, SARS-CoV-2 test positive
Clinical narrative: 8/19/21 history of developmental delay, DM type 2 not on insulin, HLD, hypothyroidism, venous insufficiency who presents for evaluation of lower extremity edema and dysuria
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dizziness, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: 8/21/21  presents for hypoxia and lightheadedness that was brought on by standing.  He has history of diabetes, obesity, CAD, HTN,  And BPH
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, COVID-19, SARS-CoV-2 test positive
Clinical narrative: 5/27/21 PMH of lap gastric bypass 2018, chronic back pain, DM, HTN presents with severe epigastric pain
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, COVID-19, Exposure during pregnancy, SARS-CoV-2 test positive
Clinical narrative: 6/29/21 G2P0010 at 35w5d by L=1st  presenting to triage complaining of elevated BPs
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Mental status changes, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: 9/4/21 PMH most significant for DM2, CAD s/p CABG, PVD; presents to Hospital for AMS 9/5/21 pt transfered to other Hospital via EMS for AMS and elevated trops
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Gait inability, Musculoskeletal stiffness, Pain
Clinical narrative: 8/20/21 PMH of polio, non-ambulatory, presents with progressive pain, weakness and stiffness.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 8/20/21 PMH of polio, non-ambulatory, presents with progressive pain, weakness and stiffness.
Age: 14.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Diarrhoea, Laboratory test, SARS-CoV-2 test positive, Vomiting
Clinical narrative: 9/6/21 PMH of Phelan-McDermid Syndrome (22q13 deletion), and Pica (which she eats her hair) who presented for 3-4 week hx  of vomiting and diarrhea.  She was diagnosed with COVID infection on September 2, 2021
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Malaise, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: 8/29/21 no significant PMH; presents with a 6 day history of malaise and cough. 6 days ago he had a positive COVID test.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: 9/10/21 PMH of perforated diverticulitis s/p Hartmann's at hospital c/b right ureteral injury s/p ureteral reimplantation, LOA, and repair of serosal defect in TI c/o abscess, fistula
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, COVID-19, Nausea, SARS-CoV-2 test positive, Vomiting
Clinical narrative: 9/8/21 PMH of HTN, Hyperlipidemia, CKD, Developmentally Delayed, Neurogenic Bladder, Bipolar Disorder, GERD, Nephrolithiasis and Asthma; presented to ER with c/o N/V and abdominal pain
Age: 52.0
Sex: M
Vaccine: VARZOS
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: Overall fatigue, body ache and throughout the day, a bit fever in the afternoon.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in my ears.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Respiratory symptom, SARS-CoV-2 test positive
Clinical narrative: 7/28/21 h/o BPH, DM, CAD s/p PCI, HTN, glaucoma, and HLP who presents with 2 day history of generalized weakness and URI symptoms
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Diabetic ketoacidosis, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: 6/3/21 PMHx of HTN, CAD, OSA, ESRD on CAPD, T1DM, GERD, admitted for AMS secondary to DKA
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Body temperature increased, COVID-19, Chest X-ray normal, Hypoxia, Mental status changes
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 01/12/2021.  79 y/o female with PMHx of hypothyroidism, dementia, HTN, GERD, and hx of right breast cancer with possible mets presents to ED from nursing home after testing Covid + on 4/18.  Pt with AMS and hypoxia per NH.  Upon arrival to ED, pt with temp of 102.7, room air sat 95% but placed on 5L NC for resp distress. Sepsis alert in ED. CXR with no focal consolidation.  Pt started on IV ABX, Steroids and Remdesivir.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Respiratory distress, SARS-CoV-2 test positive, Sepsis, Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 01/12/2021.  79 y/o female with PMHx of hypothyroidism, dementia, HTN, GERD, and hx of right breast cancer with possible mets presents to ED from nursing home after testing Covid + on 4/18.  Pt with AMS and hypoxia per NH.  Upon arrival to ED, pt with temp of 102.7, room air sat 95% but placed on 5L NC for resp distress. Sepsis alert in ED. CXR with no focal consolidation.  Pt started on IV ABX, Steroids and Remdesivir.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aphasia, COVID-19, Dyspnoea, Exposure to SARS-CoV-2, Malaise
Clinical narrative: 8/26/21 presents to urgent care requesting COVID-19 testing due to experiencing COVID-19 symptoms and exposure to COVID-19 8/27/21 PMH of CAD s/p PCI, HTN, Hyperlipidemia, COPD, Tobacco Abuse, Obesity and RA who presented to ER with c/o SOB and difficulty with speech
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 8/26/21 presents to urgent care requesting COVID-19 testing due to experiencing COVID-19 symptoms and exposure to COVID-19 8/27/21 PMH of CAD s/p PCI, HTN, Hyperlipidemia, COPD, Tobacco Abuse, Obesity and RA who presented to ER with c/o SOB and difficulty with speech
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: 8/24/21 hx of HTN, HLD, hypothyroid, CVA, OSA, GERD, lumbar spinal stenosis, who presented to ED for evaluation of fever
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Exposure during pregnancy, SARS-CoV-2 test positive, Spontaneous rupture of membranes
Clinical narrative: 7/23/21 G1P0 at 39w6d by 1TUS presents to Triage with c/o SROM
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Diarrhoea, Encephalopathy, Fatigue
Clinical narrative: 8/11/21 PMH dermatomyositis, GERD, hepatic steatosis, hypothyroidism, LTACH placement, s/p intubation and tracheostomy subsequently reversed. Presented w/complaints of worsening encephalopathy, decreased PO intake, diarrhea, profound fatigue and weakness
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypophagia, SARS-CoV-2 test positive
Clinical narrative: 8/11/21 PMH dermatomyositis, GERD, hepatic steatosis, hypothyroidism, LTACH placement, s/p intubation and tracheostomy subsequently reversed. Presented w/complaints of worsening encephalopathy, decreased PO intake, diarrhea, profound fatigue and weakness
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: 8/3/21 PMH of diabetes mellitus, type II;  presents for cough and SOB after exposure and positive covid test at urgent care
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, COVID-19, Nausea, SARS-CoV-2 test positive
Clinical narrative: 8/9/21 history of stage 3 CKD, HTN, presenting with acute onset abdominal pain and persistent nausea
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 8/7/21 PMH most significant for Afib, CKD, HTN  presents with chief complaint of shortness of breath
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, COVID-19, Hypotension, SARS-CoV-2 test positive
Clinical narrative: 6/3/21 PMHx CKD, asthma, IDDM presents to ER by EMS for elevated blood sugar and hypotension
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Exposure during pregnancy, SARS-CoV-2 test positive, Vaginal haemorrhage
Clinical narrative: 9/8/21 G2P0102 at 31w5d presents to triage with c/o vaginal bleeding.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hallucination, Headache, Myalgia, Nausea
Clinical narrative: Fever over 101f, nausea, dry fetching, headache, hallucinations, dizziness, muscle aches. Nausea persisted for 1 week.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Retching
Clinical narrative: Fever over 101f, nausea, dry fetching, headache, hallucinations, dizziness, muscle aches. Nausea persisted for 1 week.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Dysuria, Herpes simplex test negative, Nausea, Pain, Urine analysis normal
Clinical narrative: Extreme vaginal discomfort- vaginal blisters, itching, discharge, pain while urinating, nausea due to pain level Pediatrician and Obgyn appointment (tested for bladder infection, yeast infection and herpes with negative test results on all) but no treatment taken-gradually resolved itself within a week
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal discharge, Vaginal mucosal blistering, Vulvovaginal discomfort, Vulvovaginal pruritus
Clinical narrative: Extreme vaginal discomfort- vaginal blisters, itching, discharge, pain while urinating, nausea due to pain level Pediatrician and Obgyn appointment (tested for bladder infection, yeast infection and herpes with negative test results on all) but no treatment taken-gradually resolved itself within a week
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anxiety, COVID-19, Condition aggravated, SARS-CoV-2 test positive
Clinical narrative: 7/1/21  h/o ADD on adderall and anxiety presents with increased anxiety
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Muscular weakness, SARS-CoV-2 test positive
Clinical narrative: 8/12/21 unknown PMH; presents for right upper and right lower extremity weakness
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Musculoskeletal chest pain, SARS-CoV-2 test positive
Clinical narrative: 8/14/21 hx of SLE on chronic steroids, adrenal insufficiency, HTN, Sjogren's, DM, fibromyalgia, avascular necrosis of hips, RA, TIA vs seizures. Presented for left rib pain, shortness of breath and worsening cough
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Throat tightness
Clinical narrative: Patient arrived in our office stating that she felt like her throat was closing and trouble swallowing after receiving COVID vaccine Today at Pharm. Patient given 0.3mL EPI IM and Transported via EMS to ED.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Chest pain, Exposure to SARS-CoV-2, Nausea, SARS-CoV-2 test positive
Clinical narrative: 8/31/21 hx of HTN, HLD, GERD, who presented to BHS-RO ED w/ complaints of chest pain, N/V. Pt w/ +COVID exposure and subsequently tested positive at urgent care.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: 8/31/21 hx of HTN, HLD, GERD, who presented to BHS-RO ED w/ complaints of chest pain, N/V. Pt w/ +COVID exposure and subsequently tested positive at urgent care.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Chest pain, Cough, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 8/31/21 hx of HTN, HLD, GERD, who presented to BHS-RO ED w/ complaints of chest pain, N/V. Pt w/ +COVID exposure and subsequently tested positive at urgent care.
Age: 97.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: 9/8/21 hx of CAD, HTN, CHF, OA, gait instability, who presented as directed by her PCP, due to coronavirus concerns.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 7/21/21 PMH of hypertension, obesity, CKD, left bundle branch block, CAD status post CABG, mechanical falls, hyperlipidemia and chronic pain; presented with shortness of breath
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Dyspnoea, Nausea
Clinical narrative: 9/3/21 hx of HTN, DM-II, HLD, obesity, asthma, OSA, R knee OA s/p R-TKA 8/24/21 who presented to the ED for evaluation of increasing shortness of breath, persistent cough, body aches, nausea, vomiting and diarrhea
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, SARS-CoV-2 test positive, Vomiting
Clinical narrative: 9/3/21 hx of HTN, DM-II, HLD, obesity, asthma, OSA, R knee OA s/p R-TKA 8/24/21 who presented to the ED for evaluation of increasing shortness of breath, persistent cough, body aches, nausea, vomiting and diarrhea
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: 9/5/21 PMH COPD, OSA, Afib on apixaban, CKD stage 5, HTN, HLD, and breast CA who presented to the hospital with dyspnea
Age: 24.0
Sex: M
Vaccine: ANTH, COVID19
Symptoms: Chills, Sleep disorder
Clinical narrative: 10  hours after receiving vaccines patient awoke with moderate to severe chills and shivering. Over next 6 hours woken several times due to chills , drifting in and out of sleep. At 6:15 patient got out of bed, and dressed for the day. Lingering chills, but shivering has stopped.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Dizziness, Dyspnoea, Pyrexia
Clinical narrative: 7/28/21 significant past medical history of HTN, DM2, and squamous cell carcinoma of chest wall; presents w/a chief complaint of SOB, fever, lightheadedness, and cough
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 7/28/21 significant past medical history of HTN, DM2, and squamous cell carcinoma of chest wall; presents w/a chief complaint of SOB, fever, lightheadedness, and cough
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, Dyspnoea, Hepatic function abnormal, Rhabdomyolysis
Clinical narrative: 5/27/21 presented to the ER w/progressive shortness of breath & acute kidney injury w/rhabdomyolysis  & elevated liver function. PMH of hypothyroidism, gout, gastroesophageal reflux disease & hypertension.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 5/27/21 presented to the ER w/progressive shortness of breath & acute kidney injury w/rhabdomyolysis  & elevated liver function. PMH of hypothyroidism, gout, gastroesophageal reflux disease & hypertension.
Age: 86.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: 7/3/21 PMH of DVT on eliquis, L carotid aneurysm, HTN, skin cancer, hypothyroid; presented for a CC of unresponsive episode
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: 9/10/21 PMH of PAF on eliquis, B-cell lymphoma, DM II, GERD, HTN, who presents for COVID
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 9/11/21 PMH of Granulomatous Polyangiitis, CKD, CVA, Hypertension and Polymyalgia Rheumatica; presented for shortness of breath
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 9/1/21 hx of HTN,DM, and GERD; presented w/ SOB
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cervical cord compression, Condition aggravated, Intensive care, Post procedural complication
Clinical narrative: 8/18/21 PMH of cord compression. Underwent C3-7 posterior cervical laminectomy, and posterior fusion. Course complicated further cord compression from posterior drift of cord immediate post operatively. Returned immediately to OR for C1-C2 laminectomy with extension of fusion. Admitted to SICU for close hemodynamic and neuro-monitoring
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Spinal cord disorder, Spinal fusion surgery, Spinal laminectomy
Clinical narrative: 8/18/21 PMH of cord compression. Underwent C3-7 posterior cervical laminectomy, and posterior fusion. Course complicated further cord compression from posterior drift of cord immediate post operatively. Returned immediately to OR for C1-C2 laminectomy with extension of fusion. Admitted to SICU for close hemodynamic and neuro-monitoring
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Fatigue, SARS-CoV-2 test positive
Clinical narrative: 8/17/21 history of htn, DM2 presenting to the ED with complaints of fatigue with exertion
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Myalgia, Pyrexia
Clinical narrative: 8/5/21 PMH of non obstructive CAD, chronic diastolic CHF, chronic venous insufficiency, OSA on CPAP,  obesity, severe COVID-19, DM II, asthma, diabetic neuropathy, left foot chronic ulcer and essential HTN.  Presented to ED with fever of 100.5, non productive cough, shortness of cough and myalgias
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 8/5/21 PMH of non obstructive CAD, chronic diastolic CHF, chronic venous insufficiency, OSA on CPAP,  obesity, severe COVID-19, DM II, asthma, diabetic neuropathy, left foot chronic ulcer and essential HTN.  Presented to ED with fever of 100.5, non productive cough, shortness of cough and myalgias
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cholangitis sclerosing, Liver transplant, Nausea, SARS-CoV-2 test positive
Clinical narrative: 9/8/21 PSC s/p liver transplant on Cellcept and Prograf, who was sent in today per hepatology due to nausea and vomiting.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: 9/8/21 PSC s/p liver transplant on Cellcept and Prograf, who was sent in today per hepatology due to nausea and vomiting.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: 5/28/21 PMH HTN, HLD, BPH, prostate cancer with bone mets undergoing chemo presented to ER with concern for developing sepsis/shock
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: 8/3/21 h/o CAD s/p CABG and PCI, HLD, bipolar disorder who presented from urgent care for cough, SOB,  found to be hypoxic
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dizziness, Fatigue, SARS-CoV-2 test positive
Clinical narrative: 8/23/21 PMH of CVA, Hypothyroidism, Hypertension, and Bells palsy who presented to the ED with  dizziness and fatigue
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: 9/10/21 PMHx of pancreatic cancer, CAD, CKD; presents w/ fever and weakness for past several days
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Wound drainage
Clinical narrative: 9/1/21 PMH of DM, Crohns disease , GERD, HLD, Hypothryoidims, melanoma, CAD, & carconpoid tumor presented for evaluation of increased wound drainage
Age: 93.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Fall, SARS-CoV-2 test positive
Clinical narrative: 9/6/21 PMH of anemia, MM, hypothyroidism, HTN who presents with generalized weakness and falls
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea exertional, SARS-CoV-2 test positive
Clinical narrative: 6/1/21 PMH significant for CAD s/p PCI and 3 vessel CABG 2010 (LIMA-LAD, SVG-RCA, SVG-OM), HFrEF (~20% 8/2020), atrial fibrillation on Coumadin, MR, T2DM, HTN, HLD, PVD . Presented w/chief complaint of dyspnea on exertion.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: 9/9/21 hx of hypertension, comes in with history of acute on chronic back pain, accompanied by bilateral lower extremity paresthesias
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Fall, SARS-CoV-2 test positive
Clinical narrative: 8/30/21 on HD, DM, previous AVR on coumadin, paroxysmal atrial fib, AICD. Presented to hospital after mechanical fall at home 9/13/21 pt transferred to hospital due to possible compression of nerve
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fall, SARS-CoV-2 test positive
Clinical narrative: 7/7/21 hx of A-fib on Eliquis, CHF, COPD that presents as a lvl 1 trauma after fall
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, COVID-19, Pyrexia, SARS-CoV-2 test positive, Vaginal haemorrhage
Clinical narrative: 6/10/21 unknown pmhx, presents with worsening abdominal pain, increasing vaginal bleeding, and fever of 100.7
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Catheter site haemorrhage, Central venous catheterisation, SARS-CoV-2 test positive
Clinical narrative: 8/23/21 PMH of mitral valve endocarditis d/t E Cloacae (on IV Ertapenem), decompensated alcoholic cirrhosis currently on transplant list, esophageal varices, IDA, IBS, tobacco abuse who presents for complaint of bleeding from PICC line site.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure during pregnancy, Hypertension, Induced labour, SARS-CoV-2 test positive
Clinical narrative: 7/5/21 G2P1001 at 39+0/7 weeks GA by 1st trimester US not c/w LMP. Direct admit IOL for chronic HTN controlled with oral antihypertensives
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Delivery, Exposure during pregnancy, SARS-CoV-2 test positive
Clinical narrative: 7/29/21 G2P2 F, presents via ems after spontaneous delivery of baby F at home
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: 9/6/21 PMH of Alzheimer's, HTN, Hypothyroidism, and DM2; presents with a chief complaint of weakness and fever
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 antibody test positive, SARS-CoV-2 test positive
Clinical narrative: 6/3/21 PMH COPD, RLL lung resection, CHF, HTN, DVT s/p IVC filter, factor V Leiden presenting for progressive dyspnea
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dizziness, Fall, SARS-CoV-2 test positive
Clinical narrative: 9/8/21 history of atrial fibrillation, carotid artery stenosis, MI, CAD, diastolic CHF, and COPD; presents w/chief complaints of dizziness, fall, cough
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Exposure during pregnancy, Muscle spasms, SARS-CoV-2 test positive
Clinical narrative: 6/21/21 G1P0 at 39w2d by LMP c/w 20w US presents to Triage with c/o intermittent back cramping
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Hypoxia, Nasal congestion, SARS-CoV-2 test positive
Clinical narrative: 8/5/21 Patient reports cough, nasal congestion x few days; tested positive for covid 8/10/21 hx covid vaccine developed covid infection; hx RA on minimal rituxumib. Chief complaint is covid hypoxia
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, COVID-19, Fall, SARS-CoV-2 test positive
Clinical narrative: 8/20/21 PMH PAD, BPH, Arthritis, Aortic atherosclerosis, Urinary retention, chronic low back pain, sepsis d/t UTI. Pt admitted for fall at home while on blood thinners.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Pneumonia, Respiratory distress, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: 8/18/21 PMH of dementia AOx2 at baseline, HTN, recent admission for treatment of pneumonia who presents from nursing facility for respiratory distress and unresponsiveness